Valuation : Ainos, Inc.

Market Cap 1.06Cr 91.61L 86.75L 78.63L 1.48Cr 101.58Cr 1.48Cr 10Cr 3.96Cr 52Cr 3.99Cr 3.91Cr 163.31Cr P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 2.12Cr 1.83Cr 1.73Cr 1.57Cr 2.94Cr 202.69Cr 2.96Cr 21Cr 7.9Cr 103.12Cr 7.97Cr 7.79Cr 325.84Cr EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
24.76%
Yield 2024 *
-
Yield 2025 -
1 day+0.70%
1 week-10.00%
Current month+2.86%
1 month-3.36%
3 months-24.61%
6 months-1.37%
Current year-12.20%
1 week 1.4
Extreme 1.4
1.6
1 month 1.37
Extreme 1.37
1.67
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.44
3 years 1.26
Extreme 1.26
21.6
5 years 1.26
Extreme 1.26
450
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
03/06/26 Buy

Director

2,000 0.0286%
28/05/26 Buy

Director

250 0.0036%
27/05/26 Buy

Director

2,000 0.0286%
Change 5-day change 1-year change 3-year change Capi.($)
+0.70%-10.00%-59.55%-91.27% 1.06Cr
+1.10%-0.65%+27.19%+19.34% 23TCr
-0.19%-3.62%+5.31%-19.41% 14TCr
+2.41%+0.67%-17.91%+22.42% 13TCr
-0.28%-10.08%-58.15%-19.54% 6.23TCr
-2.77%-6.15%+8.77%+14.99% 4.86TCr
-0.49%-1.97%-19.72%-15.81% 4.94TCr
+2.66%-2.61%+19.22%+30.28% 4.14TCr
+1.67%-0.25%+38.24%+56.84% 4.01TCr
-0.60%-4.41%-19.20%+46.52% 3.12TCr
Average +0.42%-4.08%-7.58%+4.44% 7.7TCr
Weighted average by Cap. +0.67%-2.50%+2.73%+10.75%

Financials

2024 2025
Net sales 20.73T 17.86T 16.91T 15.33T 28.76T 19.8L 28.9T 2L 77.24T 10.08L 77.85T 76.14T 31.84L 1L 1L 1L 91.81T 2L 1.19Cr 2L 12.03L 5L 60.35L 5L 5L 1.91Cr
Net income -1.49Cr -1.28Cr -1.21Cr -1.1Cr -2.06Cr -142Cr -2.07Cr -14Cr -5.54Cr -72Cr -5.58Cr -5.46Cr -228.27Cr -1.48Cr -1.27Cr -1.21Cr -1.09Cr -2.05Cr -141.12Cr -2.06Cr -14Cr -5.5Cr -72Cr -5.55Cr -5.43Cr -226.86Cr
Net Debt 81.07L 69.85L 66.14L 59.95L 1.12Cr 77Cr 1.13Cr 7.86Cr 3.02Cr 39Cr 3.04Cr 2.98Cr 124.51Cr 1.06Cr 91.18L 86.34L 78.25L 1.47Cr 101.1Cr 1.48Cr 10Cr 3.94Cr 51Cr 3.97Cr 3.89Cr 162.53Cr
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
11/26/11 $1.440 +0.70% 23,204
10/26/10 $1.430 -3.38% 14,651
09/26/09 $1.480 0.00% 34,231
08/26/08 $1.480 -7.50% 41,535
04/26/04 $1.600 +2.56% 46,677
  1. Stock Market
  2. Stocks
  3. AIMD Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!